Wonhwa Cho

Find an error

Name: Wonhwa, Cho,
Organization: University of Illinois at Chicago , USA
Department: 1 Department of Chemistry
Title: Professor(PhD)

TOPICS

Co-reporter:Dr. Shu-Lin Liu;Dr. Ren Sheng;Matthew J. O'Connor;Yang Cui;Dr. Youngdae Yoon;Svetlana Kurilova;Dr. Daesung Lee;Dr. Wonhwa Cho
Angewandte Chemie International Edition 2014 Volume 53( Issue 52) pp:14387-14391
Publication Date(Web):
DOI:10.1002/anie.201408153

Abstract

Lipids regulate a wide range of biological activities. Since their local concentrations are tightly controlled in a spatiotemporally specific manner, the simultaneous quantification of multiple lipids is essential for elucidation of the complex mechanisms of biological regulation. Here, we report a new method for the simultaneous in situ quantification of two lipid pools in mammalian cells using orthogonal fluorescent sensors. The sensors were prepared by incorporating two environmentally sensitive fluorophores with minimal spectral overlap separately into engineered lipid-binding proteins. Dual ratiometric analysis of imaging data allowed accurate, spatiotemporally resolved quantification of two different lipids on the same leaflet of the plasma membrane or a single lipid on two opposite leaflets of the plasma membrane of live mammalian cells. This new imaging technology should serve as a powerful tool for systems-level investigation of lipid-mediated cell signaling and regulation.

Co-reporter:Robert V. Stahelin;Raymond E. Forslund;Donald J. Wink
Biochemistry and Molecular Biology Education 2003 Volume 31(Issue 2) pp:
Publication Date(Web):3 NOV 2006
DOI:10.1002/bmb.2003.494031020182

A new course for undergraduate biochemistry laboratory has been developed in the Department of Chemistry at the University of Illinois at Chicago. The course is innovative pedagogically by giving students a set of relevant skills for biochemical research and then allowing them to apply those skills in designing and performing the procedures for a research-like project. The course content focuses on the pharmacologically important enzyme β-lactamase, which is involved in the hydrolysis of antibiotics such as penicillins and cephalosporins. Specifically, each student designs and performs site-directed mutagenesis of the enzyme β-lactamase and analyzes the effect of mutation on the catalytic function of the enzyme by an enzyme assay. This unique and valuable research experience greatly enhances their understanding of scientific reasoning and the research process. Evaluation of the progress also indicates successful linkage of skill-building and student-directed activities even for students with no prior experience.

Co-reporter:Jack E. Dixon;Sudipto Das
PNAS 2003 Volume 100 (Issue 13 ) pp:7491-7496
Publication Date(Web):2003-06-24
DOI:10.1073/pnas.0932835100
PTEN is a tumor suppressor that reverses the action of phosphoinositide 3-kinase by catalyzing the removal of the 3′ phosphate of phosphoinositides. Despite the critical role of PTEN in cell signaling and regulation, the mechanisms of its membrane recruitment and activation is still poorly understood. PTEN is composed of an N-terminal phosphatase domain, a C2 domain, and a C-terminal tail region that contains the PSD-95/Dlg/ZO-1 homology (PDZ) domain-binding sequence and multiple phosphorylation sites. Our in vitro surface plasmon resonance measurements using immobilized vesicles showed that both the phosphatase domain and the C2 domain, but not the C-terminal tail, are involved in electrostatic membrane binding of PTEN. Furthermore, the phosphorylation-mimicking mutation on the C-terminal tail of PTEN caused an ≈80-fold reduction in its membrane affinity, mainly by slowing the membrane-association step. Subcellular localization studies of PTEN transfected into HEK293T and HeLa cells indicated that targeting of PTEN to the plasma membrane is coupled with rapid degradation and that the phosphatase domain and the C2 domain are both necessary and sufficient for its membrane recruitment. Results also indicated that the phosphorylation regulates the targeting of PTEN to the plasma membrane not by blocking the PDZ domain-binding site but by interfering with electrostatic membrane binding of PTEN. On the basis of these results, we propose a membrane-binding and activation mechanism for PTEN, in which the phosphorylation/dephosphorylation of the C-terminal region serves as an electrostatic switch that controls the membrane translocation of the protein.
Co-reporter:Dae Heon Kim, Mi-Jeong Park, Gwang Hyeon Gwon, Antonina Silkov, ... Inhwan Hwang
Developmental Cell (8 September 2014) Volume 30(Issue 5) pp:598-609
Publication Date(Web):8 September 2014
DOI:10.1016/j.devcel.2014.07.026
•The chloroplast protein-targeting mechanism evolved from both host and endosymbiont•The chloroplast-targeting factor AKR2A derived from a host cell ankyrin repeat domain•Endosymbiotic cyanobacteria lipids MGDG and PG are AKR2A receptors on chloroplasts•The ankyrin repeat domain changed for coincident/synergistic MGDG/PG lipid bindingIn organellogenesis of the chloroplast from endosymbiotic cyanobacteria, the establishment of protein-targeting mechanisms to the chloroplast should have been pivotal. However, it is still mysterious how these mechanisms were established and how they work in plant cells. Here we show that AKR2A, the cytosolic targeting factor for chloroplast outer membrane (COM) proteins, evolved from the ankyrin repeat domain (ARD) of the host cell by stepwise extensions of its N-terminal domain and that two lipids, monogalactosyldiacylglycerol (MGDG) and phosphatidylglycerol (PG), of the endosymbiont were selected to function as the AKR2A receptor. Structural analysis, molecular modeling, and mutational analysis of the ARD identified two adjacent sites for coincidental and synergistic binding of MGDG and PG. Based on these findings, we propose that the targeting mechanism of COM proteins was established using components from both the endosymbiont and host cell through a modification of the protein-protein-interacting ARD into a lipid binding domain.Download high-res image (345KB)Download full-size image
Co-reporter:Yong Chen, Ren Sheng, Morten Källberg, Antonina Silkov, ... Wonhwa Cho
Molecular Cell (27 April 2012) Volume 46(Issue 2) pp:226-237
Publication Date(Web):27 April 2012
DOI:10.1016/j.molcel.2012.02.012
Emerging evidence indicates that membrane lipids regulate protein networking by directly interacting with protein-interaction domains (PIDs). As a pilot study to identify and functionally annodate lipid-binding PIDs on a genomic scale, we performed experimental and computational studies of PDZ domains. Characterization of 70 PDZ domains showed that ∼40% had submicromolar membrane affinity. Using a computational model built from these data, we predicted the membrane-binding properties of 2,000 PDZ domains from 20 species. The accuracy of the prediction was experimentally validated for 26 PDZ domains. We also subdivided lipid-binding PDZ domains into three classes based on the interplay between membrane- and protein-binding sites. For different classes of PDZ domains, lipid binding regulates their protein interactions by different mechanisms. Functional studies of a PDZ domain protein, rhophilin 2, suggest that all classes of lipid-binding PDZ domains serve as genuine dual-specificity modules regulating protein interactions at the membrane under physiological conditions.Graphical AbstractDownload high-res image (306KB)Download full-size imageHighlights► Membrane-binding PDZ domains are identified and classified on a genomic scale ► Many PDZ domains serve as a dual-specificity lipid- and protein-binding module ► Lipid binding of PDZ domains regulates their function by different mechanisms
5H-Benzo[a]phenoxazin-5-one, 9-(diethylamino)-2-(2-propenyloxy)-
Novel protein kinase C
D-myo-Inositol,1-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl hydrogen phosphate] 5-(dihydrogenphosphate) (9CI)
Benzenesulfonamide,N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-4-methyl-N-(2-methylpropyl)-
N-[1(S)-Benzyl-2(R)-hydroxy-3-[N-isobutyl-N-(4-methoxyphenylsulfonyl)amino]propyl]carbamic acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
5H-Benzo[a]phenoxazin-5-one, 9-(diethylamino)-2-hydroxy-